1EXEL:BIT
Exelixis Inc
€45.30
arrow_upward
+1.30%(+0.58) 1D
Jun 2, 9:27:08 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1EXEL...
Mkt. cap
13.25B
Avg. vol.
59.00
Volume
0.00
52-wk high
€45.30
52-wk low
€29.27
No. of employees
1K
Mkt. cap
13.25B
Avg. vol.
59.00
Volume
0.00
52-wk high
€45.30
52-wk low
€29.27
No. of employees
1K
News stories
From sources across the web
Yahoo Finance
·
1 day ago
Exelixis (EXEL) Up 6% Since Last Earnings Report: Can It Continue?
Investing.com
·
2 days ago
Exelixis director Sue Eckhardt sells $491,973 in stock
TipRanks
·
2 days ago
Exelixis Stock Jumps as New Cancer Data Impresses
Profile
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
About Exelixis Inc
CEOMichael M. Morrissey
Employees1.08K
FoundedNov 15, 1994
HeadquartersAlameda, California, United States
SectorBiotechnology
Websiteexelixis.com
AI content may include mistakes. Learn more